Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunangelo Falini

Showing results (61-70 of 246) with videos related to

Pageof 25
Sort By:
American Journal of Hematology|April 29, 2023
The NPM1 mutant defines AML irrespective of blast countBrunangelo Falini, Maria Paola Martelli, Lorenzo Brunetti, et al.
Blood Reviews|December 25, 2012
Mutational landscape of AML with normal cytogenetics: biological and clinical implicationsMaria Paola Martelli, Paolo Sportoletti, Enrico Tiacci, et al.
Nature Cell Biology|June 25, 2002
Nucleophosmin regulates the stability and transcriptional activity of p53Emanuela Colombo, Jean-Christophe Marine, Davide Danovi, et al.
Ejhaem|October 17, 2024
Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cellsLorenzo Brunetti, Giulia Pianigiani, Michael C Gundry, et al.
British Journal of Haematology|July 26, 2018
A BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expressionEdoardo Simonetti, Stefano Ascani, Stefano Volpetti, et al.
Discovery Medicine|November 2, 2010
New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issuesBrunangelo Falini, Enrico Tiacci, Maria Paola Martelli, et al.
Haematologica|January 3, 2012
The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemiaEnrico Tiacci, Vera Grossmann, Maria Paola Martelli, et al.
Histopathology|July 17, 2013
Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markersRoshanak Bob, Brunangelo Falini, Teresa Marafioti, et al.
Minerva Medica|September 21, 2020
Enasidenib and ivosidenib in AMLMaria Paola Martelli, Giovanni Martino, Valeria Cardinali, et al.
Blood Reviews|July 5, 2011
Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?Brunangelo Falini, Ilaria Gionfriddo, Federica Cecchetti, et al.
Pageof 25

Showing results (61-70 of 246) with videos related to

Sort By:
Pageof 25
American Journal of Hematology|April 29, 2023
The NPM1 mutant defines AML irrespective of blast countBrunangelo Falini, Maria Paola Martelli, Lorenzo Brunetti, et al.
Blood Reviews|December 25, 2012
Mutational landscape of AML with normal cytogenetics: biological and clinical implicationsMaria Paola Martelli, Paolo Sportoletti, Enrico Tiacci, et al.
Nature Cell Biology|June 25, 2002
Nucleophosmin regulates the stability and transcriptional activity of p53Emanuela Colombo, Jean-Christophe Marine, Davide Danovi, et al.
Ejhaem|October 17, 2024
Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cellsLorenzo Brunetti, Giulia Pianigiani, Michael C Gundry, et al.
British Journal of Haematology|July 26, 2018
A BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expressionEdoardo Simonetti, Stefano Ascani, Stefano Volpetti, et al.
Discovery Medicine|November 2, 2010
New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issuesBrunangelo Falini, Enrico Tiacci, Maria Paola Martelli, et al.
Haematologica|January 3, 2012
The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemiaEnrico Tiacci, Vera Grossmann, Maria Paola Martelli, et al.
Histopathology|July 17, 2013
Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markersRoshanak Bob, Brunangelo Falini, Teresa Marafioti, et al.
Minerva Medica|September 21, 2020
Enasidenib and ivosidenib in AMLMaria Paola Martelli, Giovanni Martino, Valeria Cardinali, et al.
Blood Reviews|July 5, 2011
Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?Brunangelo Falini, Ilaria Gionfriddo, Federica Cecchetti, et al.
Pageof 25